TriPath Imaging to Present at Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference
June 08 2006 - 4:58PM
PR Newswire (US)
BURLINGTON, N.C., June 8 /PRNewswire-FirstCall/ -- TriPath Imaging,
Inc. (NASDAQ:TPTH) today announced that its management is scheduled
to speak at the Needham & Company, LLC Fifth Annual
Biotechnology and Medical Technology Conference in New York City at
the New York Palace Hotel on Thursday, June 15, 2006 at 10:00 a.m.
ET about the Company's financial performance, business and
development highlights and future expectations. An audio web cast
of the presentation will be available live online via TriPath
Imaging's website at http://www.tripathimaging.com/ and will be
archived for at least two weeks. TriPath Imaging, Inc.,
headquartered in Burlington, North Carolina, develops,
manufactures, markets and sells innovative solutions to improve the
clinical management of cancer, including detection, diagnosis,
staging and treatment. TriPath Oncology, a wholly owned subsidiary
of TriPath Imaging, develops and manages the market introduction of
molecular diagnostic products for malignant melanoma and cancers of
the cervix, breast, ovary and prostate. Contact Stephen P. Hall
Chief Financial Officer 336-290-8721 DATASOURCE: TriPath Imaging,
Inc. CONTACT: Stephen P. Hall, Chief Financial Officer of TriPath
Imaging, Inc., +1-336-290-8721 Web site:
http://www.tripathimaging.com/
Copyright
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Tripath Imaging (NASDAQ): 0 recent articles
More Tripath Imaging Inc. (MM) News Articles